Skip to main content

Table 2 Pattern of failure and cause of death

From: Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma

Variable

No. of patients (%)

Pattern of failure

N Group

CRT Group

P

Distant metastasis

5a (15.6%)

7b (12.7%)

0.753

Local and/or regional failures

10a (31.3%)

19b (34.5%)

0.753

Local failures alone

3 (9.4%)

9 (16.4%)

0.523

Regional failures alone

1 (3.1%)

1 (1.8%)

1.000

Local and regional failures

6 (18.8%)

9 (16.4%)

0.776

Distant + local/regional failures

2 (6.3%)

5 (9.0%)

1.000

Total

13 (43.8%)

21 (38.2%)

0.822

Cause of death

Tumor progression

8 (25.0%)

7 (12.7%)

0.144

Distant metastasis

2 (6.3%)

1 (1.8%)

0.552

Local or regional failure

5 (15.6%)

2 (3.6%)

0.095

Distant + local/regional failures

1 (3.1%)

4 (7.3%)

0.648

Radiation-related complications

8 (25.0%)

18 (32.7%)

0.448

Organ failure caused by tumor

1 (3.1%)

1 (1.8%)

1.000

No cancer causes

4 (12.5%)

1 (1.8%)

0.059

Unknown causes

0 (0.0%)

1 (1.8%)

1.000

Total

21 (65.6%)

28 (50.9%)

0.182

  1. a The number includes the two patients with both distant and local/regional failures; b The number includes the five patients with both distant and local/regional failures